Company / Free Cash Flow
Enovis Free Cash Flow History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow
$19.9M
FY2025
5-year range
-$67.2M / $251.9M
FY2021-FY2025
Trend
+129.6%
vs FY2024
Sector context
#107 of 151
Health Care
What the data says
At $20M, Enovis's free cash flow ranks #107 of 151 in the Health Care sector. Free Cash Flow has fluctuated over the past 10 years, ranging from -$67M in FY2024 to $252M in FY2023.
Based on SEC 10-K filings.
$20M in FY2025 with a 5-year CAGR of -33.8%.
Declined from $252M to $20M over the past 2 years.
Health Care sector context is included.
Free Cash Flow over time
Growth rates
- 3-Year CAGR
- -52.6%
- 5-Year CAGR
- -33.8%
- 10-Year CAGR
- -
Sector benchmark
#107 of 151 in Health CareTop 71% of 151This company $19.9M Sector average $779.8M
▼
-97.4% below sector average
Key checks
Key Insights
- 5-year CAGR of -33.8%, indicating a declining trend.
- In FY2025, free cash flow increased 129.6% year-over-year.
- Ranks #107 out of 151 companies in the Health Care sector.
- Peak free cash flow was recorded in FY2023.
Company context
Key Data Points
- Altman Z-Score -0.27 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $19.9M | +129.6% |
| FY2024 | -$67.2M | -126.7% |
| FY2023 | $251.9M | +34.6% |
| FY2022 | $187.2M | -25.7% |
| FY2021 | $251.9M | +60.7% |
| FY2020 | $156.7M | +4.5% |
| FY2019 | $150.0M | -4.3% |
| FY2018 | $156.7M | -33.0% |
| FY2017 | $233.9M | +27.3% |
| FY2016 | $183.7M | -36.8% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026